Netstreit maintains 2026 AFFO per share at $1.37-$1.39 while lifting net investment outlook to at least $800M
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
The drop is a sharp reversal of a massive 2026 stock rally fueled by optimism over its personalized cancer vaccine.
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Royal Bank of Canada’s capital markets division named Sara Mahaffy as head of Canadian equity strategy, marking the first time in a decade it’s had a dedicated strategist covering the domestic stock…